STEM CELL THERAPIES FOR ENTERIC NEUROPATHIES
Dr Lincon Stamp,
Senior Research Fellow & Group Leader,
Department of Anatomy and Physiology,
School of Biomedical Sciences,
The University of Melbourne, Victoria, Australia
RESEARCHER PROFILE
Filmed in Melbourne, Australia | October 2025
Dr Stamp is a Group Leader in the Department of Anatomy and Physiology at the University of Melbourne, Australia. Dr Stamp’s PhD research (with Prof Martin Pera, Monash University) focused on the derivation of hepatopancreatic progenitors from human embryonic stem cells. He then joined the lab of Dr Don Newgreen at the Murdoch Childrens Research Institute where he began working on development of the enteric nervous system (ENS), before joining Prof Heather Young’s lab at the University of Melbourne, where he focused on developing a stem cell therapy to treat gut motility disorders such as the paediatric enteric neuropathy Hirschprung disease.
His lab, which he runs together with Dr Marlene Hao, is now focused on the development, plasticity, and cell and gene therapies for the digestive system, with a particular focus on the enteric nervous system.
Dr Stamp has a strong national and international network of collaborators, including key clinical and consumer connections, and has published high impact studies in top tier journals including Gastroenterology, JCI and Nature Reviews Gastroenterology and Hepatology.
He has had success at securing significant government (ARC, MRFF), philanthropic (NSCFA, REACH Foundation) and industry (Takeda Pharmaceuticals) funding, has strong ties within the Australian and international stem cell communities, and is the currently the President of the Australasian Society for Stem Cell Research (ASSCR).
Source: Supplied
https://orcid.org/0000-0002-8925-7894
-
Radiation therapy techniques and combination treatments for sarcoma
Professor Angela Hong MBBS, MMed, PhD, FRANZCR is a Professor at Sydney Medical School of the University of Sydney. She is a radiation oncologist and has been a member of the Multidisciplinary Bone and Soft Tissue Tumour Clinic at Royal Prince Alfred Hospital/Chris O’Brien Lifehouse for the past 15 years.
As a radiation oncologist located in Sydney, Australia, Professor Hong is focused on treating patients with bone and soft tissue sarcoma. And as a clinician scientist, her research focuses on developing innovative radiation therapy technique and combination treatments to improve the outcome for patients with sarcoma.
-
Electrical stimulation on organic conductors
Professor Gordon Wallace AO is the Founder and Director of the Intelligent Polymer Research Institute (IPRI) at the University of Wollongong and Founding Director of the Australian National Fabrication Facility (ANFF) Materials Node. He was previously the Executive Director of the ARC Centre of Excellence for Electromaterials Science (ACES).
-
Neonatal respiratory trials in sick & preterm newborn infants
Prof Brett J. Manley leads and collaborates on large national and international randomised clinical trials in neonatology. He previously collaborated on 4 randomised trials of nasal high-flow as non-invasive respiratory support for preterm and term infants, all of which were published in N Engl J Med. Recently he led the PLUSS trial of intratracheal budesonide for extremely preterm infants, that recruited in 21 NICUs across 4 countries, the results of which were published in JAMA. PLUSS was awarded the Australian Clinical Trials Alliance Trial of the Year in 2025. Another passion of his is mentoring and supervising early career researchers to undertake their own clinical trials.
